Profil
Dr. Roland Wandeler is a President-Biopharma Business Unit at Grifols SA. Dr. Wandeler was previously employed as a Chief Executive Officer by Encinal Bio, Inc., a Chief Operating Officer by MorphoSys AG, and a VP, GM-US Bone Health & Cardiology Business Unit by Amgen, Inc. He received his graduate degree from Swiss Federal Institute of Technology and a doctorate degree from Swiss Federal Institute of Technology.
Aktiva positioner av Roland Wandeler
| Företag | Position | Start |
|---|---|---|
| GRIFOLS, S.A. | Företagsledare/Principal | 2024-01-01 |
Tidigare kända positioner av Roland Wandeler
| Företag | Position | Slut |
|---|---|---|
Encinal Bio, Inc. | Verkställande Direktör | 2023-10-01 |
| MORPHOSYS AG | Verksamhetschef | 2021-12-31 |
| AMGEN INC. | Företagsledare/Principal | - |
Roland Wandelers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Grifols SA
Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Encinal Bio, Inc. |
















